Signet Industries [SIGIND] vs Chemo-Pharma [CPL] Detailed Stock Comparison

Signet Industries

NSE
Loading...

Chemo-Pharma

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Signet Industries wins in 9 metrics, Chemo-Pharma wins in 10 metrics, with 0 ties. Chemo-Pharma appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSignet IndustriesChemo-PharmaBetter
P/E Ratio (TTM)11.1711.95Signet Industries
Price-to-Book Ratio0.782.52Signet Industries
Debt-to-Equity Ratio165.8944.70Chemo-Pharma
PEG Ratio0.060.61Signet Industries
EV/EBITDA7.4813.68Signet Industries
Profit Margin (TTM)1.34%11.11%Chemo-Pharma
Operating Margin (TTM)8.64%9.62%Chemo-Pharma
EBITDA Margin (TTM)8.64%9.62%Chemo-Pharma
Return on Equity6.69%20.97%Chemo-Pharma
Return on Assets (TTM)1.85%11.26%Chemo-Pharma
Free Cash Flow (TTM)$117.80M$41.66MSignet Industries
Dividend Yield0.78%N/AN/A
1-Year Return-19.30%-10.86%Chemo-Pharma
Price-to-Sales Ratio (TTM)0.151.39Signet Industries
Enterprise Value$7.36B$4.59BSignet Industries
EV/Revenue Ratio0.621.57Signet Industries
Gross Profit Margin (TTM)17.74%29.30%Chemo-Pharma
Revenue per Share (TTM)$795$51Signet Industries
Earnings per Share (Diluted)$5.26$5.66Chemo-Pharma
Beta (Stock Volatility)0.350.23Chemo-Pharma
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Signet Industries vs Chemo-Pharma Stock Performance Analysis

Loading Price Chart...

Signet Industries
Chemo-Pharma
Signet Industries Stock Overview | Chemo-Pharma Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Signet Industries-1.86%3.43%4.87%-12.65%28.65%-18.74%
Chemo-Pharma0.37%1.22%-10.60%-11.27%-19.24%-41.64%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Signet Industries-19.30%27.99%201.10%-83.76%121.68%121.68%
Chemo-Pharma-10.86%284.53%120.36%729.71%1,225.59%1,225.59%

News Based Sentiment: Signet Industries vs Chemo-Pharma

Signet Industries

News based Sentiment: MIXED

September brought a mixed bag for Signet Industries. While the company reported strong profit growth, revenue declined, creating a complex picture for investors. The dividend announcement and share price fluctuations add further layers to the investment story, making it a significant month for the company.

View Signet Industries News Sentiment Analysis

Chemo-Pharma

News based Sentiment: NEGATIVE

The significant financial losses reported in Q1 FY26, coupled with underperformance relative to the Sensex, create a concerning picture for investors. While the diversification strategy is a positive development, it doesn't immediately offset the current challenges. The volatile stock price and fluctuating investor participation add to the uncertainty.

View Chemo-Pharma News Sentiment Analysis

Performance & Financial Health Analysis: Signet Industries vs Chemo-Pharma

MetricSIGINDCPL
Market Information
Market Cap i₹1.85B₹4.05B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i7,63632,878
90 Day Avg. Volume i6,58433,955
Last Close₹57.66₹67.87
52 Week Range₹39.99 - ₹88.65₹66.00 - ₹128.00
% from 52W High-34.96%-46.98%
All-Time High₹745.00 (Jan 25, 2016)₹128.00 (Jan 06, 2025)
% from All-Time High-92.26%-46.98%
Growth Metrics
Quarterly Revenue Growth0.03%0.08%
Quarterly Earnings Growth0.39%0.34%
Financial Health
Profit Margin (TTM) i0.01%0.11%
Operating Margin (TTM) i0.09%0.10%
Return on Equity (TTM) i0.07%0.21%
Debt to Equity (MRQ) i165.8944.70
Cash & Liquidity
Book Value per Share (MRQ)₹75.48₹26.86
Cash per Share (MRQ)₹3.07₹1.01
Operating Cash Flow (TTM) i₹-10,333,000₹277.99M
Levered Free Cash Flow (TTM) i₹156.42M₹313.23M
Dividends
Last 12-Month Dividend Yield i0.78%N/A
Last 12-Month Dividend i₹0.50₹0.00

Valuation & Enterprise Metrics Analysis: Signet Industries vs Chemo-Pharma

MetricSIGINDCPL
Price Ratios
P/E Ratio (TTM) i11.1711.95
Forward P/E iN/AN/A
PEG Ratio i0.060.61
Price to Sales (TTM) i0.151.39
Price to Book (MRQ) i0.782.52
Market Capitalization
Market Capitalization i₹1.85B₹4.05B
Enterprise Value i₹7.36B₹4.59B
Enterprise Value Metrics
Enterprise to Revenue i0.621.57
Enterprise to EBITDA i7.4813.68
Risk & Other Metrics
Beta i0.350.23
Book Value per Share (MRQ) i₹75.48₹26.86

Financial Statements Comparison: Signet Industries vs Chemo-Pharma

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SIGINDCPL
Revenue/Sales i₹2.60B₹697.42M
Cost of Goods Sold i₹2.13B₹493.08M
Gross Profit i₹460.28M₹204.34M
Research & Development iN/AN/A
Operating Income (EBIT) i₹224.25M₹67.12M
EBITDA i₹251.76M₹79.31M
Pre-Tax Income i₹10.90M₹55.13M
Income Tax i₹4.03M₹12.13M
Net Income (Profit) i₹6.87M₹42.99M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SIGINDCPL
Cash & Equivalents i₹11.06M₹12.05M
Total Current Assets i₹7.55B₹2.51B
Total Current Liabilities i₹5.70B₹1.17B
Long-Term Debt i₹358.17M₹109.50M
Total Shareholders Equity i₹2.34B₹1.49B
Retained Earnings iN/AN/A
Property, Plant & Equipment i₹723.08M₹144.04M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SIGINDCPL
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSIGINDCPL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i7,63632,878
Average Daily Volume (90 Day) i6,58433,955
Shares Outstanding i29.44M57.55M
Float Shares i17.00M17.06M
% Held by Insiders i0.73%0.70%
% Held by Institutions i0.00%0.00%

Dividend Analysis & Yield Comparison: Signet Industries vs Chemo-Pharma

MetricSIGINDCPL
Last 12-Month Dividend i₹0.50₹0.00
Last 12-Month Dividend Yield i0.78%N/A
3-Year Avg Annual Dividend i₹0.50₹0.00
3-Year Avg Dividend Yield i0.90%N/A
3-Year Total Dividends i₹1.50₹0.00
Ex-Dividend DateSep 17, 2024N/A